Benefits of Surgical Treatment of Stage IV Breast Cancer for Patients With Known Hormone Receptor and HER2 Status
Kelly A. Stahl, William G. Wong, Daleela Dodge, Ashton J. Brooks, Christopher McLaughlin, Elizabeth J. Olecki, Joseph A. Lewcun, Kristina Newport, Monali Vasekar, Chan Shen
Topics & Concepts
MedicineHazard ratioBreast cancerInternal medicineOncologySurgical oncologyProportional hazards modelHormone receptorHormone therapySystemic therapyCancerChemotherapyStage (stratigraphy)Estrogen receptorHormonal therapyConfidence intervalGynecologyPaleontologyBiologyBreast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer Research